Pyxis Oncology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.9 | $16.1 | — | — | — |
| Operating income | -$84.4 | -$89.5 | -$82.2 | -$123.5 | -$69.7 |
| Net income | -$79.6 | -$77.3 | -$73.8 | -$120.7 | -$76.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$63.5 | -$57.9 | -$77.4 | -$95.7 | -$35.9 |
Shares outstanding 83.4M · Free float 64.2%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.